Daclizumab HYP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Daclizumab HYP, covering 2017-03-14 to 2017-03-14. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis [Phase 3]